1. Alderson N., 2005. Overview of FDA’s Activities at the Nano-Bio Interface, presentation at the Nanotechnology-Biology Interface: Exploring Models for Oversight, University of Minnesota, September 15.
2. Baird D., 2005. Philosophical Issues in Future Applications, presentation at the Nanotechnology-Biology Interface: Exploring Models for Oversight, University of Minnesota, September 15.
3. Bergeson L., 2005. Overview of EPA’s Activities at the Nano-Bio Interface, presentation at the Nanotechnology-Biology Interface: Exploring Models for Oversight, University of Minnesota, September 15.
4. Cobb M., Macoubrie J. (2004) Public perceptions about nanotechnology: Risks, benefits and trust. J. Nanopart. Res. 6:395–405
5. Environmental Protection Agency (EPA), 2005a. Overview of Issues for Consideration by NPPTAC. Available at http://www.epa.gov/oppt/npptac/nanowgoverviewdocument20051109 .pdf.